ENHERTU® PLUS PERTUZUMAB APPROVED IN THE EU AS FIRST NEW REGIMEN IN MORE THAN A DECADE FOR FIRST-LINE TREATMENT OF PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER

Reuters · 3d ago

Please log in to view news